Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/16911
Title: | Matrix metalloproteinases as therapeutic targets in protozoan parasitic infections | Authors: | GEURTS, Nathalie OPDENAKKER, Ghislain Van den Steen, Philippe E. |
Issue Date: | 2012 | Publisher: | PERGAMON-ELSEVIER SCIENCE LTD | Source: | PHARMACOLOGY & THERAPEUTICS, 133 (3), p. 257-279 | Abstract: | Matrix metalloproteinases (MMPs) are associated with processes of tissue remodeling and are expressed in all infections with protozoan parasites. We here report the status of MMP research in malaria, trypanosomiasis, leishmaniasis and toxoplasmosis. In all these infections, the balances between MMPs and endogenous MMP inhibitors are disturbed, mostly in favor of active proteolysis. When the infection is associated with leukocyte influx into specific organs, immunopathology and collateral tissue damage may occur. These pathologies include cerebral malaria, sleeping sickness (human African trypanosomiasis), Chagas disease (human American trypanosomiasis), leishmaniasis and toxoplasmic encephalitis in immunocompromised hosts. Destruction of the integrity of the blood-brain barrier (BBB) is a common denominator that may be executed by leukocytic MMPs under the control of host cytokines and chemokines as well as influenced by parasite products. Mechanisms by which parasite-derived products alter host expression of MMP and endogenous MMP inhibitors, have only been described for hemozoin (Hz) in malaria. Hence, understanding these interactions in other parasitic infections remains an important challenge. Furthermore, the involved parasites are also known to produce their own metalloproteinases, and this forms an extra stimulus to investigate MMP inhibitory drugs as therapeutics. MMP inhibitors (MMPIs) may dampen collateral tissue damage, as is anecdotically reported for tetracyclines as MMP regulators in parasite infections. | Notes: | [Geurts, Nathalie; Opdenakker, Ghislain; Van den Steen, Philippe E.] Univ Leuven, Rega Inst Med Res, Immunobiol Lab, B-3000 Louvain, Belgium. | Keywords: | matrix metalloproteinases; inhibitor; parasite; malaria; trypanosomiasis; leishmaniasis; toxoplasmosis; blood–brain barrier; cerebrospinal fluid;Matrix metalloproteinases; Inhibitor; Parasite; Malaria; Trypanosomiasis; Leishmaniasis; Toxoplasmosis; Blood-brain barrier; Cerebrospinal fluid | Document URI: | http://hdl.handle.net/1942/16911 | ISSN: | 0163-7258 | e-ISSN: | 1879-016X | DOI: | 10.1016/j.pharmthera.2011.11.008 | ISI #: | 000301217700001 | Rights: | © 2011 Elsevier Inc. All rights reserved. | Category: | A1 | Type: | Journal Contribution |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Geurts, 2012 review.pdf Restricted Access | 1.6 MB | Adobe PDF | View/Open Request a copy |
SCOPUSTM
Citations
63
checked on Sep 3, 2020
WEB OF SCIENCETM
Citations
76
checked on Oct 12, 2024
Page view(s)
170
checked on Jun 28, 2023
Download(s)
136
checked on Jun 28, 2023
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.